Autolus Therapeutics
Presence
Syncona is one of the...
Syncona is a company listed under the stock ticker SYNC (GB).
Syncona has a direct presence in 3 countries.Syncona has 13 subsidiaries including Achilles Therapeutics, Anaveon and Autolus Therapeutics.
They are in:
- Biotechnology86%
- Holding7%
- Other7%
Acquisition, funding and merger involving Syncona.
- Syncona has announced the acquisition of Beacon Therapeutics (posted on October 28 2022).
Executives
View the org chart displaying its 24 main executives
Most searched biographies at Autolus Therapeutics
- Christian Itin, Chief Executive Officer and Director
- Joe Anderson, Non-Executive Director
- Linda Bain, Director
Popular executive movements at Autolus Therapeutics
- John Johnson, Chairman of the Board, has left the company (posted on April 2 2024).
- Michael Bonney has joined the company as Chairman of the Board (posted on April 2 2024).
- Robert Azelby has joined the company as Director (posted on January 11 2024).
Click here to view some more movements at Autolus Therapeutics
Create your alert
to follow the executive moves at Autolus Therapeutics.
Biotechnology
Syncona has 2,287 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Autolus Therapeutics
Social media about Autolus Therapeutics
- Autolus Therapeutics on Wikipedia, Google News & Yahoo Finance
- Autolus Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Christian Itin 
Call Autolus Therapeutics at +44 203...
